PD-1-overexpressing macrophages are the major TAMs in ESCC and are significantly associated with poor prognosis, and phagocytosis by macrophages is enhanced after anti-PD-1 treatment. Here, PDCD1 is linked to esophageal squamous cell carcinoma.